search
Back to results

Kharituwe TB Contact Tracing Study

Primary Purpose

Tuberculosis, Hiv

Status
Active
Phase
Not Applicable
Locations
South Africa
Study Type
Interventional
Intervention
Household contact tracing
Sponsored by
Johns Hopkins Bloomberg School of Public Health
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Tuberculosis

Eligibility Criteria

undefined - 99 Years (Child, Adult, Older Adult)All SexesAccepts Healthy Volunteers

TB index cases:

Inclusion criteria:

  • Age 0-99 years
  • Diagnosed with microbiologically confirmed pulmonary TB at a study hospital or clinic

Exclusion criteria:

  • Unwilling/unable to provide informed consent
  • Plan not to pursue TB treatment within the study district
  • Unwilling/unable to comply with study procedures

Contacts:

Inclusion criteria:

  • Age 0-99 years
  • Currently resides with or visiting eligible TB index case

Exclusion Criteria:

  • Unwilling/unable to provide informed consent
  • Unwilling/unable to comply with study procedures

Sites / Locations

  • Perinatal HIV Research Unit (PHRU)
  • Setshaba Research Centre

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Experimental

Experimental

Arm Label

Standard Tracing

Holiday Tracing

Evening / Weekend Tracing

Arm Description

Households of tuberculosis index patients receive "standard" household contact tracing during regular weekday business hours.

Households of tuberculosis index patients in rural South Africa receive household contact tracing during holidays (Christmas and Easter).

Households of tuberculosis index patients in urban South Africa receive household contact tracing during evenings and weekends.

Outcomes

Primary Outcome Measures

Effectiveness: ratio of secondary TB identified and started on treatment per index case in novel strategy arm compared to standard contact investigation arm
The ratio of the number of secondary TB cases identified and started on treatment per index case in the novel strategy arm (off-peak screening in Soshanguve and holiday screening in Limpopo) compared to index cases receiving standard contact investigation.

Secondary Outcome Measures

The TB prevalence ratio, comparing highly mobile to less mobile index patients
The TB prevalence ratio, comparing highly mobile to less mobile individuals, measuring mobility on two scales (neighborhood/intra-urban and regional/intra-national). For the analysis: amount of time spent in transit, truncating long excursions at 50km (one hour).
TB strain relatedness using maximum likelihood transmission trees.
TB natural history, epidemiological, and whole genome sequencing (WGS)-derived phylogenetic data will be integrated into a statistical modeling framework to draw probabilistic conclusions about the likelihood of transmission between persons. "Transmitters" will be defined as individuals from whom at least one secondary case most likely originated.
Relative acceptability of each novel strategy compared to standard contact investigation
Relative acceptability of each novel strategy, compared against routine contact investigation. Acceptability of the intervention will be measured among index cases and contacts using a short questionnaire given to a randomly selected participant at a randomly selected 15% of the households visited. The interview will cover acceptability of the visit timing, notification, visit activities (TB screening, HIV testing) and study team interaction among others.
Feasibility of each strategy: proportion of potentially eligible index cases for whom a household visit was conducted
Feasibility of each strategy as the proportion of potentially eligible index cases for whom a household visit was conducted. All reasons why visits were unable to be conducted will be recorded (e.g. could not find household, no one ever home, visit not conducted during expected off-peak period).
Relative fidelity of each novel strategy compared to standard contact investigation
Relative fidelity of each novel strategy using a process checklist for each index case and household, including whether the household visit was offered and accepted, whether the visit was attempted, whether the visit was successful (i.e., enrolled at least one contact), whether symptom screening and sputum collection were completed and whether newly identified TB cases were notified and referred for treatment.
Sustainability of each novel strategy relative to standard contact tracing
Sustainability of each novel strategy by reporting the primary outcome and fidelity measures according to six-month time period over the course of the study.
Incremental cost-effectiveness ratio for each novel strategy relative to standard contact tracing
Defined as (cost of contact tracing strategy 2 - cost of strategy 1)/(effectiveness of strategy 2 - effectiveness of strategy 1), where effectiveness is modeled as the number of disability-adjusted life years (DALYs) averted by the intervention. The primary cost-effectiveness measures will be the incremental cost per DALY averted using novel strategies (holiday and off-hours contact tracing) compared to routine contact tracing in each setting separately.

Full Information

First Posted
August 7, 2020
Last Updated
October 4, 2023
Sponsor
Johns Hopkins Bloomberg School of Public Health
Collaborators
Perinatal HIV Research Unit of the University of the Witswatersrand, Setshaba Research Centre
search

1. Study Identification

Unique Protocol Identification Number
NCT04520113
Brief Title
Kharituwe TB Contact Tracing Study
Official Title
Innovative Contact Tracing Strategies for Detecting TB in Mobile Rural and Urban South African Populations
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
September 1, 2020 (Actual)
Primary Completion Date
June 2024 (Anticipated)
Study Completion Date
June 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Johns Hopkins Bloomberg School of Public Health
Collaborators
Perinatal HIV Research Unit of the University of the Witswatersrand, Setshaba Research Centre

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to characterize the role of human mobility in fueling TB epidemics and estimate the potential impact of innovative case finding interventions tailored to mobile populations
Detailed Description
The investigators propose a randomized trial of two novel TB case-finding interventions among household members of patients diagnosed with active TB: holiday-based screening in a rural South African province (Limpopo) and off-peak (weekend/evening) screening in an urban settlement into which many residents of Limpopo migrate for work. The investigators will enroll index cases of TB plus their household contacts in each setting and randomize them to novel versus standard contact investigation. In Specific Aim 1, investigators will use whole genome sequencing of all cases, overlaying transmission trees with data on human movement, to evaluate associations between mobility and TB transmission in this population. In Specific Aim 2, investigators will employ a multidisciplinary approach to compare novel versus standard contact investigation in each setting along the following dimensions: (a) effectiveness (number of secondary TB cases diagnosed and starting treatment); (b) implementation (reach, fidelity, and maintenance of contact investigation outside of business hours); (c) cost-effectiveness (cost per disability-adjusted life year) and budget impact; and (d) projected population-level impact on TB incidence. Successful completion of these aims will have long-term impact by characterizing the role of mobility in fueling TB epidemics and testing two tailored approaches to improve TB control in highly mobile populations - an underserved group that is increasingly recognized as playing a major role in global TB transmission.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Tuberculosis, Hiv

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Investigator
Masking Description
The principal investigators are blinded as to the assignment of treatment to participants
Allocation
Randomized
Enrollment
15000 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Standard Tracing
Arm Type
Active Comparator
Arm Description
Households of tuberculosis index patients receive "standard" household contact tracing during regular weekday business hours.
Arm Title
Holiday Tracing
Arm Type
Experimental
Arm Description
Households of tuberculosis index patients in rural South Africa receive household contact tracing during holidays (Christmas and Easter).
Arm Title
Evening / Weekend Tracing
Arm Type
Experimental
Arm Description
Households of tuberculosis index patients in urban South Africa receive household contact tracing during evenings and weekends.
Intervention Type
Behavioral
Intervention Name(s)
Household contact tracing
Intervention Description
Household contact tracing to test and diagnose Tuberculosis of household contacts of Tuberculosis patients.
Primary Outcome Measure Information:
Title
Effectiveness: ratio of secondary TB identified and started on treatment per index case in novel strategy arm compared to standard contact investigation arm
Description
The ratio of the number of secondary TB cases identified and started on treatment per index case in the novel strategy arm (off-peak screening in Soshanguve and holiday screening in Limpopo) compared to index cases receiving standard contact investigation.
Time Frame
Duration of study (30 months)
Secondary Outcome Measure Information:
Title
The TB prevalence ratio, comparing highly mobile to less mobile index patients
Description
The TB prevalence ratio, comparing highly mobile to less mobile individuals, measuring mobility on two scales (neighborhood/intra-urban and regional/intra-national). For the analysis: amount of time spent in transit, truncating long excursions at 50km (one hour).
Time Frame
Duration of study (30 months)
Title
TB strain relatedness using maximum likelihood transmission trees.
Description
TB natural history, epidemiological, and whole genome sequencing (WGS)-derived phylogenetic data will be integrated into a statistical modeling framework to draw probabilistic conclusions about the likelihood of transmission between persons. "Transmitters" will be defined as individuals from whom at least one secondary case most likely originated.
Time Frame
Duration of study (30 months)
Title
Relative acceptability of each novel strategy compared to standard contact investigation
Description
Relative acceptability of each novel strategy, compared against routine contact investigation. Acceptability of the intervention will be measured among index cases and contacts using a short questionnaire given to a randomly selected participant at a randomly selected 15% of the households visited. The interview will cover acceptability of the visit timing, notification, visit activities (TB screening, HIV testing) and study team interaction among others.
Time Frame
Duration of study (30 months)
Title
Feasibility of each strategy: proportion of potentially eligible index cases for whom a household visit was conducted
Description
Feasibility of each strategy as the proportion of potentially eligible index cases for whom a household visit was conducted. All reasons why visits were unable to be conducted will be recorded (e.g. could not find household, no one ever home, visit not conducted during expected off-peak period).
Time Frame
Duration of study (30 months(
Title
Relative fidelity of each novel strategy compared to standard contact investigation
Description
Relative fidelity of each novel strategy using a process checklist for each index case and household, including whether the household visit was offered and accepted, whether the visit was attempted, whether the visit was successful (i.e., enrolled at least one contact), whether symptom screening and sputum collection were completed and whether newly identified TB cases were notified and referred for treatment.
Time Frame
Duration of study (30 months)
Title
Sustainability of each novel strategy relative to standard contact tracing
Description
Sustainability of each novel strategy by reporting the primary outcome and fidelity measures according to six-month time period over the course of the study.
Time Frame
Duration of study (30 months)
Title
Incremental cost-effectiveness ratio for each novel strategy relative to standard contact tracing
Description
Defined as (cost of contact tracing strategy 2 - cost of strategy 1)/(effectiveness of strategy 2 - effectiveness of strategy 1), where effectiveness is modeled as the number of disability-adjusted life years (DALYs) averted by the intervention. The primary cost-effectiveness measures will be the incremental cost per DALY averted using novel strategies (holiday and off-hours contact tracing) compared to routine contact tracing in each setting separately.
Time Frame
Duration of study (30 months)

10. Eligibility

Sex
All
Maximum Age & Unit of Time
99 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
TB index cases: Inclusion criteria: Age 0-99 years (Including those recently deceased) Diagnosed with pulmonary TB at a study hospital or clinic (microbiological and/or chest x-ray diagnosis) Exclusion criteria: Unwilling/unable to provide informed consent (including next of kin, for those recently deceased) Plan not to pursue TB treatment within the study district Unwilling/unable to comply with study procedures Contacts: Inclusion criteria: Age 0-99 years Currently resides with or visiting eligible TB index case Exclusion Criteria: Unwilling/unable to provide informed consent Unwilling/unable to comply with study procedures
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
David W. Dowdy, MD, PhD
Organizational Affiliation
Johns Hopkins Bloomberg School of Public Health
Official's Role
Principal Investigator
Facility Information:
Facility Name
Perinatal HIV Research Unit (PHRU)
City
Johannesburg
Country
South Africa
Facility Name
Setshaba Research Centre
City
Soshanguve
Country
South Africa

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Kharituwe TB Contact Tracing Study

We'll reach out to this number within 24 hrs